MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹490 Cr | ₹501 Cr | ₹402 Cr | ₹321 Cr | ₹456 Cr |
What is the latest Total Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹490 Cr |
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹402 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹456 Cr |
How is Total Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹490 Cr | -2.07 | |
| Mar2025 | ₹501 Cr | 24.53 | |
| Mar2024 | ₹402 Cr | 25.18 | |
| Mar2023 | ₹321 Cr | -29.64 | |
| Mar2022 | ₹456 Cr | - | |
Compare Total Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,195.0 Cr | 5.7% | -22% | 104.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 5.7% |
-22% |
104.2% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses